Archive: 28/09/2019

Ovarian cancer: more women benefit from maintenance combined targeted therapy

New data presented at the ESMO Congress 2019 in Barcelona, Spain, show the benefit of a more intensive maintenance regimen for ovarian cancer with the PARP inhibitor olaparib added to bevacizumab, in an all-comers population, ...

Sep 28, 2019

0

5

Two immunotherapy drug combination offers chemotherapy-free option for advanced NSCLC

New data have shown that first-line treatment with a combination of two immunotherapy drugs improves overall survival in a subset of patients with advanced non-small cell lung cancer (NSCLC) compared to chemotherapy.

Sep 28, 2019

0

4

Front-line osimertinib improves overall survival in EGFR-mutation positive NSCLC

First-line osimertinib significantly lengthens overall survival compared to older generation EGFR-TKIs in patients with Ex19del/L858R EGFR mutated advanced non-small cell lung cancer (NSCLC), according to late breaking results ...

Sep 28, 2019

0

6

New treatment improves survival in women newly diagnosed with advanced ovarian cancer

An international study demonstrates that administering niraparib after conventional chemotherapy treatment in patients newly diagnosed with advanced ovarian cancer, improves their progression-free survival, and reduces their ...

Sep 28, 2019

0

5

PARP inhibitor plus chemotherapy improves progression-free survival for advanced ovarian cancer patients

Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that initial treatment with the PARP inhibitor veliparib in combination with chemotherapy significantly increased progression-free ...

Sep 28, 2019

Liquid biopsy has prognostic role in colorectal cancer and potential for guiding therapy

Liquid biopsy is likely to play an increasing role in identifying patients with colorectal cancer (CRC) who are likely to relapse after surgery, and has potential for optimising treatment for individual patients, according ...

Sep 28, 2019

0

4

His heart stopped. But his golf cart kept going

On a sunny April day in 2018, Bill Doss pushed through his exhaustion and met his buddies for their regular round of golf. As he headed to the final tee, he was rounding a turn in his cart and his world went black.

Sep 28, 2019

1

6

Cases of legionnaires' disease tied to NC state fair rise to 25

(HealthDay)—The number of cases of Legionnaires' disease tied to the North Carolina Mountain State fair has risen to 25, with one death, according to the state division of public health.

Sep 28, 2019

0

6

Swiss chocolatier Callebaut all-in on cacao

Swiss chocolatier Barry Callebaut on Friday unveiled a new formulation that packs in the parts of the cacao fruit it used to toss away, taking aim at younger generations.

Sep 28, 2019

1

7

Keep calm and vape on: UK embraces e-cigarettes, US cautious

While the U.S. scrambles to crack down on vaping, Britain has embraced electronic cigarettes as a powerful tool to help smokers kick the habit.

Sep 28, 2019

0

9

page 1 from 2

«
»